Related Experiment Video
Updated: Jan 28, 2026

Identification of Orexin and Endocannabinoid Receptors in Adult Zebrafish Using Immunoperoxidase and Immunofluorescence Methods
Published on: June 25, 2019
ABHD6: Its Place in Endocannabinoid Signaling and Beyond
Jessica K Cao1, Joshua Kaplan1, Nephi Stella2
1Department of Pharmacology, University of Washington, Seattle, WA, USA.
Abstract:
The endocannabinoid (eCB) signaling system modulates neurotransmission and inflammation, among other physiological functions. Its newest member, α/β-hydrolase domain-containing 6 (ABHD6), has emerged as a promising therapeutic target to treat several devastating diseases, including epilepsy. Here, we review the molecular mechanisms that mediate and control eCB signaling and, within it, the specific role of ABHD6. We also discuss how ABHD6 controls the abundance of additional lipids and the trafficking of ionotropic receptors to plasma membranes. We finish with several unexplored questions regarding this novel enzyme. Our current understanding of the molecular mechanism and biological function of ABHD6 provides a strong foundation for the development of small-molecule therapeutics to treat devastating diseases.
More Related Videos
Related Concept Videos
What is Cell Signaling?
Endocrine Signaling
Paracrine Signaling
Bacterial Signaling
Synaptic Signaling
Yeast Signaling

